Initial testing (stage 1) of the polo‐like kinase inhibitor volasertib (BI 6727), by the Pediatric Preclinical Testing Program
暂无分享,去创建一个
S. Keir | J. Maris | P. Houghton | R. Lock | Malcolm A. Smith | R. Gorlick | Min H. Kang | C. Billups | R. Kurmasheva | C. Reynolds | E. Kolb | H. Carol | Malcolm A. Smith | Raushan T. Kurmasheva | Stephen T. Keir | John M. Maris | Catherine A. Billups